Director, Global Commercial Strategy – GI

Role Overview

• Serve as the commercial lead for early-stage Compound Development Teams (CDTs), embedding commercial strategy from discovery through proof-of-concept
• Translate the DAS roadmap into actionable asset-level strategies by defining priority disease spaces, patient segments, clinical value drivers, differentiation requirements, and evidence needs across the early pipeline
• Shape target product profiles (TPPs), indication sequencing, competitive positioning, and go/no-go criteria
• Provide commercial input into clinical trial design, endpoint selection, comparator strategy, patient enrichment, line-of-therapy positioning, and label-enabling evidence generation for priority GI assets
• Drive portfolio prioritization across internal programs and external innovation opportunities
• Partner with late-development program teams to translate asset strategy into launch-ready commercial plans
• Lead commercial workstreams for late-stage assets, ensuring the launch strategy is grounded with solid forecasting from regional input
• Shape pre-launch planning across target product profile refinement, launch sequencing, brand positioning, evidence generation, stakeholder engagement, and readiness milestones
• Partner with cross-functional teams to pressure-test launch assumptions, identify key risks and opportunities, and develop clear recommendations for governance and investment decisions

Requirements

• A Bachelor’s degree is required. An advanced degree preferred, including MBA, PharmD, PhD, MD, or related scientific/business discipline.
• 10+ years of progressive experience in pharmaceutical, biotech, or healthcare commercial strategy, marketing, business development, market access, medical affairs, R&D strategy, or related functions
• Demonstrated experience developing commercial strategy for pipeline, early development, late-stage, and/or launch assets, ideally in immunology, gastroenterology, or specialty medicine
• Strong understanding of drug development, clinical trial design, endpoints, regulatory considerations, evidence generation, market access, and global commercialization requirements
• Strong strategic thinking, analytical rigor, and business acumen
• Excellent written and verbal communication skills, including ability to develop executive-ready narratives, synthesize complex information, and present recommendations to senior leadership
• Demonstrated leadership behaviors consistent with Our Credo and J&J leadership expectations, including accountability, collaboration, inclusion, agility, and enterprise mindset.
• Proven ability to shape target product profiles, value propositions, asset positioning, competitive strategy, and investment recommendations in partnership with R&D, Medical Affairs, Market Access, GCI, regional teams, and Business Development
• Experience leading complex, global, cross-functional initiatives in a matrix environment, with the ability to influence senior stakeholders without direct authority.

Benefits

• inclusive work environment
• diversity and dignity of employees recognized
• consideration for employment without regard to protected characteristics
• accommodation for interview process